Grant: Research Tools and Instruments - Category 1 (<$150,000)
Queen's University
$51,255.00
Insulin assay through high performance liquid chromatography
EF 2011-12
Résumé
The direction of my NSERC supported research is to focus on insulin drug delivery using new and novel approaches in encapsulation methods and materials. The research is built around three main objectives, interrelated through insulin delivery. The first objective is to achieve long term (days and weeks) delivery of low levels of insulin from microparticles, then ultimately from microparticles embedded within natural polymer foams or films. The long-term goal is to design bioactive dressings for burn and wound injuries. The second objective is to encapsulate human islet cells together with fabricated cell matrix proteins within a polymeric particle. Canada is a leader in islet implantation therapies, and this initiative can contribute to the advancement of diabetes treatment through enhanced implanted islet viability and glucose-responsive insulin production. The third objective is to chemically modify natural polymers, providing novel biomaterials that do not exist in nature, or have not been previously synthesized. The intent is to use the new biomaterials for oral insulin delivery and other drug delivery applications.
This present application is for a High Performance Liquid Chromatograph (HPLC), with a configuration designed to follow a validated assay for insulin, often measured in a complex polymer mixture/medium. The instrument is directly related to 100% of the research being undertaken by my NSERC discovery grant. Every aspect of this research requires routine insulin assay/quantification. The HPLC is an instrument that will serve an integral role in all aspects of my research and in my training of HQP. Through my Discovery Grant, with the aid of HPLC instrumentation, training will be provided to 4 MSc and 4 PhD students over the next 5 years.
Programme
Research Tools and Instruments - Category 1 (<$150,000)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
422838-2012
Name nom
Neufeld, Ronald
Department département
Chemical Engineering
Organization id
29
Institution établissement
Queen's University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2012
Award amount
51255
Program id
EQPEQ
Program nane en
Research Tools and Instruments - Category 1 (<$150,000)
Program name fr
Outils et instruments de recherche - catégorie 1 (<150 000$)
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
1
Nb partie
1
Application title
Insulin assay through high performance liquid chromatography
Keyword
NSERC
Application summary
The direction of my NSERC supported research is to focus on insulin drug delivery using new and novel approaches in encapsulation methods and materials. The research is built around three main objectives, interrelated through insulin delivery. The first objective is to achieve long term (days and weeks) delivery of low levels of insulin from microparticles, then ultimately from microparticles embedded within natural polymer foams or films. The long-term goal is to design bioactive dressings for burn and wound injuries. The second objective is to encapsulate human islet cells together with fabricated cell matrix proteins within a polymeric particle. Canada is a leader in islet implantation therapies, and this initiative can contribute to the advancement of diabetes treatment through enhanced implanted islet viability and glucose-responsive insulin production. The third objective is to chemically modify natural polymers, providing novel biomaterials that do not exist in nature, or have not been previously synthesized. The intent is to use the new biomaterials for oral insulin delivery and other drug delivery applications.
This present application is for a High Performance Liquid Chromatograph (HPLC), with a configuration designed to follow a validated assay for insulin, often measured in a complex polymer mixture/medium. The instrument is directly related to 100% of the research being undertaken by my NSERC discovery grant. Every aspect of this research requires routine insulin assay/quantification. The HPLC is an instrument that will serve an integral role in all aspects of my research and in my training of HQP. Through my Discovery Grant, with the aid of HPLC instrumentation, training will be provided to 4 MSc and 4 PhD students over the next 5 years.